Kite Pharma, Inc. (Nasdaq: KITE) announced that the Company has entered into an exclusive, worldwide license with the National Institutes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE